FIELD: experimental medicine, particularly, oncology. SUBSTANCE: this method prescribes administering β-form of methyluracil in dose of 5 to 50 mg/kg of body mass 15 min before irradiation. EFFECT: disclosed method permits amplifying antitumoral effect and diminishing complication rate. 1 tbl
Title | Year | Author | Number |
---|---|---|---|
ANTITUMOR REMEDY | 1993 |
|
RU2034543C1 |
SUBSTANCE SHOWING RADIOPROTECTIVE EFFECT | 1993 |
|
RU2104007C1 |
METHOD FOR ACTIVATING ALVEOLAR MACROPHAGES | 1993 |
|
RU2063226C1 |
COMPOSITION SHOWING ANTIMICROBIAL EFFECT | 1993 |
|
RU2061476C1 |
SOLID MEDICINAL FORM - TABLETS WITH ELEUTHEROCOCCUS SENTICOSUS | 1992 |
|
RU2057527C1 |
METHOD FOR APPLYING PHOTON-CAPTURING TUMOR THERAPY | 2004 |
|
RU2270045C1 |
METHOD OF PROTON THERAPY FOR SOLID EHRLICH CARCINOMA | 2023 |
|
RU2808984C1 |
METHOD FOR INHIBITION OF TUMOR GROWTH | 2003 |
|
RU2255742C2 |
LOCAL ANESTHETIC OPHTHALMIC REMEDY | 1992 |
|
RU2038076C1 |
METHOD FOR INDUCTION OF AN ABSCOPAL ANTITUMOR EFFECT IN THE EXPERIMENTAL MODEL OF EHRLICH'S CARCINOMA | 2020 |
|
RU2736120C2 |
Authors
Dates
1995-09-27—Published
1993-05-18—Filed